Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 19, 2002

Primary Completion Date

April 30, 2005

Study Completion Date

May 1, 2009

Conditions
Head and Neck Cancer
Interventions
DRUG

docetaxel

DRUG

irinotecan hydrochloride

Trial Locations (43)

10461

Albert Einstein Clinical Cancer Center, The Bronx

10466

MBCCOP-Our Lady of Mercy Cancer Center, The Bronx

19713

CCOP - Christiana Care Health Services, Newark

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

49007

West Michigan Cancer Center, Kalamazoo

54449

CCOP - Marshfield Clinic Research Foundation, Marshfield

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

60201

CCOP - Evanston, Evanston

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

61801

CCOP - Carle Cancer Center, Urbana

70112

MBCCOP - LSU Health Sciences Center, New Orleans

74136

CCOP - Oklahoma, Tulsa

80112

Swedish Medical Center, Englewood

80124

Sky Ridge Medical Center, Lone Tree

80210

Porter Adventist Hospital, Denver

80218

Presbyterian - St. Luke's Medical Center, Denver

80220

Rocky Mountain Cancer Centers - Denver Rose, Denver

80221

Rocky Mountain Cancer Centers - Thornton, Thornton

80224

CCOP - Colorado Cancer Research Program, Incorporated, Denver

80501

Hope Cancer Care Center at Longmont United Hospital, Longmont

80933

Penrose Cancer Center, Colorado Springs

81004

St. Mary-Corwin Regional Medical Center, Pueblo

89106

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

94305-5216

Stanford Cancer Center at Stanford University Medical Center, Stanford

80012-0000

Medical Center of Aurora - South Campus, Aurora

80301-9019

Boulder Community Hospital, Boulder

80218-1191

St. Joseph Hospital, Denver

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

60611-4494

Veterans Affairs Medical Center - Lakeside Chicago, Chicago

61615-7828

CCOP - Illinois Oncology Research Association, Peoria

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

67214-3882

CCOP - Wichita, Wichita

02111

Tufts - New England Medical Center, Boston

49007-3731

CCOP - Kalamazoo, Kalamazoo

07601

CCOP - Northern New Jersey, Hackensack

43623-3456

CCOP - Toledo Community Hospital, Toledo

54307-3453

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

53792-0001

University of Wisconsin Comprehensive Cancer Center, Madison

53226-3596

Medical College of Wisconsin Cancer Center, Milwaukee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00040807 - Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | Biotech Hunter | Biotech Hunter